Literature DB >> 15336377

Simultaneous determination of serum flecainide and its metabolites by using high performance liquid chromatography.

Kosuke Doki1, Masato Homma, Keisuke Kuga, Shigeyuki Watanabe, Iwao Yamaguchi, Yukinao Kohda.   

Abstract

Simultaneous determination of serum flecainide and its oxidative metabolites was carried out by using high performance liquid chromatography (HPLC) equipped with conventional octadecylsilyl silica (ODS) column and fluorescence detector. Flecainide and its metabolites, m-O-dealkylated flecainide (MODF) and m-O-dealkylated lactam of flecainide (MODLF) in serum were extracted with ethyl acetate. The recoveries of flecainide, MODF and MODLF were greater than 92, 93, and 60% with the coefficient of variations (CVs) less than 3.2, 5.8, and 5.3%, respectively. The calibration curves were linear at the concentration range of 50-1500 ng/mL for flecainide and 10-500 ng/mL for MODF and MODLF (r > 0.999). The CVs for intra-day assay were 2.7-5.3% for flecainide, 3.0-4.2% for MODF, and 3.7-4.3% for MODLF, respectively. The CVs for inter-day assay were 7.0-8.4% for flecainide, 3.3-6.7% for MODF, and 4.4-7.7% for MODLF, respectively. This assay method can be used for assessing the metabolic ability of flecainide in the patients with tachyarrhythmia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336377     DOI: 10.1016/j.jpba.2004.04.009

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia.

Authors:  Kosuke Doki; Masato Homma; Keisuke Kuga; Kazutomi Kusano; Shigeyuki Watanabe; Iwao Yamaguchi; Yukinao Kohda
Journal:  Eur J Clin Pharmacol       Date:  2006-08-30       Impact factor: 2.953

2.  Treatment of chronic atrial fibrillation in the horse with flecainide: personal observation.

Authors:  F Birettoni; F Porciello; M Rishniw; G della Rocca; A Di Salvo; M Sgorbini
Journal:  Vet Res Commun       Date:  2007-08       Impact factor: 2.459

3.  Effects of CYP2D6 genotypes on age-related change of flecainide metabolism: involvement of CYP1A2-mediated metabolism.

Authors:  Kosuke Doki; Masato Homma; Keisuke Kuga; Kazutaka Aonuma; Yukinao Kohda
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

4.  Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia.

Authors:  Kosuke Doki; Masato Homma; Keisuke Kuga; Kazutaka Aonuma; Satoshi Sakai; Iwao Yamaguchi; Yukinao Kohda
Journal:  Eur J Clin Pharmacol       Date:  2007-07-31       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.